Hologic to acquire Fischer Imaging mammography assets:
This article was originally published in Clinica
Women's health imaging firm Hologic has agreed to acquire Fischer Imaging's intellectual property in the field of mammography. The Bedford, Massachusetts-based acquirer will pay $32m in cash for technology including Fischer Imaging's SenoScan digital mammography and MammoTest stereotactic breast biopsy system. Cash-strapped Fischer Imaging, which settled litigation over mammography technology with Hologic in 2002, admitted in May that there was substantial doubt over whether it could continue as a going concern. It has struggled to bring SenoScan up to the standard needed to establish a position in the emerging digital mammography market.
You may also be interested in...
A collaboration between Novo and Fauna will look at animal hibernation and genetic sequencing for hints toward novel therapies for obesity. Pfizer will use Insilico’s machine learning technology in target validation.
The introduction of gene therapies has been the highest-profile new modality to reach the market, but new RNA-based therapeutics hold significant potential and could be more accessible for patients. Scrip reviews the leading drug developers in this space.